Breaking News: FDA Approves Enzalutamide as a Treatment Option for Patients with Recurrent Prostate Cancer at High Risk of Metastases
PCF Impact on the Prostate Cancer Research Community
The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Darolutamide Challenge Awards
The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research
Washington Commanders announce month-long programming promoting early detection and celebrating survivors and those currently ungergoing treatment as part of NFL’s ‘Crucial Catch’ campaign
The Prostate Cancer Foundation Announces Inaugural $30 Million TACTICAL Awards Program for Innovative Prostate Cancer Research
UCLA, UCSF gain FDA approval for prostate cancer imaging technique
New and More Sensitive Prostate Cancer Imaging on the Near Horizon
$2.5 Million Gift from Robert Frederick Smith to the Prostate Cancer Foundation is the Largest Donation Ever Dedicated to Advancing Prostate Cancer Research in African-American Men
